Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Promis Neurosciences, Inc

Clinical trials sponsored by Promis Neurosciences, Inc, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New Alzheimer's drug shows promise in Early-Stage trial Results expected Dec 2026 (estimated)

Browse trials soon ready across all sponsors →

Not yet finished but already full! 1

New Alzheimer's drug shows promise in Early-Stage trial

Disease control Ongoing

This study tests a new drug called PMN310 in people with early Alzheimer's disease. The goal is to see if it is safe and if it can reduce signs of the disease in the brain. About 144 participants will receive multiple doses of the drug or a placebo. This is an early-phase trial, …

Phase 1 • Sponsor: ProMis Neurosciences, Inc • Aim: Disease control

Last updated Jul 15, 2026 00:00 UTC